MAC Neuroscience Centre of excellence, the early phase division of MAC Clinical Research, has been awarded Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).
MAC will be exhibiting at this year’s PCT conference in Vienna 16 – 17 November 2016.
MAC will be exhibiting at this year’s Exploratory Clinical Development World Congress in Berlin 26th – 27th October 2016.
MAC meets the Alzheimer’s disease research team with Dr Penny Foulds at Lancaster University.
MAC’s Chief Research and Development Officer, Dr John Connell will be speaking at the 35th Annual Scientific Meeting of the
MAC is attending the Early Clinical Development (ECD) meeting in London. ECD is an open forum for exchanging knowledge between Industry, Academia
Lancaster University launched the “Defying Dementia” campaign earlier this year, in order to raise awareness of Alzheimer’s and the new drug,
The European Union’s clinical outsourcing event of the year, CCH Congress Centre in Hamburg.Come and meet us at Stand 321.
A new drug developed by Lancaster University which may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. Lancaster University has filed a patent application for the drug, and it will be progressing into clinical trials run by the north-west research company MAC Clinical Research.
MAC is delighted to announce that it has won the highly coveted Health and Care Business of the Year Award
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
